Recent Headlines
EternoGen Aesthetics Completes Its Financing Round Securing $5MM to Commercialize Their First in Class Bio-Dermal Restoration Portfolio
EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of... - November 18, 2015 - EternoGen Aesthetics LLC
ReproTech Staff Discuss Fertility Preservation Options for Oncology Patients in Ft. Worth, TX
Cancer Care Services in Fort Worth, TX was the setting for a presentation entitled Fertility Preservation for the Oncology Patient. This program strives to promote education and extend access to fertility preservation services. - November 18, 2015 - ReproTech, LLC
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
Zenalux Announces Grants from the National Institute of Health for Cancer Screening
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been awarded a grant from the National Institute of Health (NIH) to further develop the Zenascope® to screen for cancer by employing imaging and reducing operator error. Zenalux is also participating in an Academic Industry... - November 06, 2015 - Zenalux Biomedical, Inc.
FastQS Announces Launch of Complaint Management Solution for Medical Device Companies
FastQS, today, announced the launch of its modern cloud-based Complaint Management Solution designed specifically for the medical device industry. With FastQS, medical device companies can easily process complaints paperlessly and compliantly. Robust complaint management is a requirement under the... - November 05, 2015 - FastQS
Salotex Has Reduced Its Services Offered
Salotex has made the decision to reduce its list of services and focus on 3 core services. Custom hearing protection, for both work and play, audiometric (hearing) testing and drug & alcohol testing. - November 05, 2015 - Salotex Health
PBTF, ABC2 Cofund Pediatric Brain Cancer Screening Research
The Pediatric Brain Tumor Foundation and ABC2 (Accelerate Brain Cancer Cure) are working together to fund the development of immunosignature-based blood tests for detecting, classifying and monitoring pediatric medulloblastoma over time. - November 04, 2015 - Pediatric Brain Tumor Foundation
DNAe Secures £25 Million ($38 Million) Bank Facility to Fund Development of Pioneering Point-of-Need IVD for Serious Blood Infections
DNAe, the inventors of semiconductor DNA sequencing technology, have secured a bank facility of £25 million ($38 million) to fund the final development stages of DNAe Diagnostics’ revolutionary point-of-need test for serious blood infections. This will include clinical trials targeted for 2016 and product launch in 2017. - November 04, 2015 - DNA Electronics
The Scientific Journal Highlights ASAlaser’s Commitment in Research
The company from Vicenza, leader in the study and implementation of laser’s therapeutic solutions, celebrates the first 7 years of Energy for Health, a magazine devoted to physical therapy. - November 01, 2015 - ASA srl
Speaking of NEC Podcast Featuring Dr. Sheila Gephart Launches October 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - October 26, 2015 - The Morgan Leary Vaughan Fund, Inc.
Clinical Trials in Russia. The Third Quarter 2015.
The Ministry of Health of the Russian Federation approved 203 new clinical trials of all types, including local and bioequivalence studies, during the 3rd Quarter of 2015. This represents a 13% increase over the same period of last year. - October 25, 2015 - Synergy Research Group
T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis
The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015 - Roots Analysis
ASAlaser Launches ASAveterinary APP
This application dedicated to the use of MLS® Laser therapy in the vet sector was created as a result of the technological research carried out by the company that leads the production of laser therapy solutions. This useful instrument, which is ready to use, is perfect for sector professionals. - October 10, 2015 - ASA srl
Matrix Medical to Unveil Enhanced TRACTUS Platform at NASS 2015
Matrix IT Medical Tracking Systems LLC has announced plans to release and demonstrate the newest version of TRACTUS. This is the world's first sterile field scanner and aids in stakeholder compliance to the FDA's UDI Final Rule. - October 07, 2015 - Matrix Medical Tracking Systems
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Northern California Motorcyclists Ride for Kids with Brain Tumors
Nearly 200 motorcyclists gathered for the Northern California Ride for Kids over the weekend to support children battling brain tumors. As of ride time, the family-friendly motorcycle event in Fairfield, Calif., had raised $59,342 to support the Pediatric Brain Tumor Foundation. The event honored... - October 07, 2015 - Pediatric Brain Tumor Foundation
Mercy Opens World’s First Virtual Care Center
Described as a “hospital without beds,” center uses technology to care for patients. - October 06, 2015 - Mercy
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Motorcyclists Contribute $167,000 to Aid Sick Children
From the Las Vegas Strip to the Capitol area, more than 700 motorcyclists gathered for children battling brain tumors over the weekend. As of ride time, the family-friendly Baltimore-Washington and Las Vegas Ride for Kids events had raised $167,459 to support the Pediatric Brain Tumor... - September 30, 2015 - Pediatric Brain Tumor Foundation
Bostonians Walk, Run for Kids with Brain Tumors
About 200 Bostonians gathered on Sept. 26 for the Starry Night Boston 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $27,074 to help fund the foundation’s lifesaving research and life-changing family support programs. The crowd gathered for the... - September 30, 2015 - Pediatric Brain Tumor Foundation
Speaking of NEC Podcast Featuring The NEC Society Launches September 28
Episode 7 features Jennifer Canvasser, Founder of the NEC Society, and Dr. Samir Gadepalli, NEC Society scientific advisory council member. In 2014, Jennifer founded the NEC Society, a non-profit organization dedicated to protecting fragile infants, after losing her son, Micah, to Necrotizing Enterocolitis. - September 24, 2015 - The Morgan Leary Vaughan Fund, Inc.
L-Mesitran's Soft is Effective in the Treatment of Ear Infections in Dogs
L-Mesitran Soft is effective when treating ear infections in dogs, even antibiotic resistant bacteria are effectively killed. It is also effective in the restoration of wounds and bacterial infections. Using medical grade honey reduces the use of antibiotics and prevents resistance. It is a good... - September 24, 2015 - Mesitran
Golden State Motorcyclists Ride for Kids with Brain Tumors
More than 330 motorcyclists gathered for children battling brain tumors at the San Diego Ride for Kids event over the weekend. As of ride time, this motorcycle event had raised $35,912 to support the Pediatric Brain Tumor Foundation. The event at Mira Costa College in Cardiff honored four local... - September 23, 2015 - Pediatric Brain Tumor Foundation
Philadelphia Athletes Complete 8.5k for Kids with Brain Tumors
The City of Brotherly Love welcomed about 750 walkers and runners on Sept. 19 for the Philadelphia Starry Night 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $47,974 to help fund the foundation’s lifesaving research and life-changing family... - September 23, 2015 - Pediatric Brain Tumor Foundation
Matrix Medical to Attend NASS 2015
Matrix IT, Medical Tracking Systems has announced plans to attend the 2015 NASS 2015 Conference, in Chicago, Illinois. NASS is a conference specifically targeted for interested stakeholders in spinal orthopedic solutions. As the FDA UDI Final Rule is fast approaching, Matrix IT is planning on... - September 20, 2015 - Matrix Medical Tracking Systems
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Motorcyclists from Coast to Coast Ride for Kids with Brain Tumors
Motorcyclists from Birmingham, Philadelphia and Puget Sound hit the road for children battling brain tumors during Ride for Kids events over the weekend. These family-friendly motorcycle events, held in Leeds, Ala., Phoenixville, Pa., Carnation, Wash., raised more than $150,000 to support the... - September 16, 2015 - Pediatric Brain Tumor Foundation
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
Clinical Imaging Board Publishes Guidance to Address Concerns in Relation to Patient Identification
The CIB published guidance and recommendations on patient identification, aimed at ensuring that the right patients always undergo the right diagnostic imaging procedures (scans, x-rays, etc). - September 07, 2015 - Insititute of Physics and Engineering in Medicine
NASH Drugs Market, 2015-2025
The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis
Protein Expression Systems Market: Current Landscape and Future Opportunities
Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis
Epitope Diagnostics Introduces Novel Fecal NGAL Specific ELISA Kit for Inflammatory Bowel Disease
Epitope Diagnostics introduces its novel fecal neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. This is the first commercial kit that is developed for measurement of NGAL levels in human stool sample. Fecal NGAL is potentially a better marker than those currently used in clinical practice. - September 01, 2015 - Epitope Diagnostics, Inc.
New England, North Carolina Motorcyclists Hit Road for Kids
From the mountains of North Carolina to history-rich sites of Massachusetts, motorcyclists hit the road over the weekend for kids battling brain tumors. These family-friendly Ride for Kids events, held in Asheville, N.C., and Framingham, Mass., raised $84,236 to support the Pediatric Brain Tumor... - August 27, 2015 - Pediatric Brain Tumor Foundation
Oral Cancer Awareness Key to Survival
Scripps Oral Pathology Service (SOPS) offers CE course in Del Mar, CA, "Oral Pathology: From Differential Diagnosis to Biopsy." - August 26, 2015 - Scripps Oral Pathology Service
Speaking of NEC Podcast Featuring Expert Parent Laura Martin Launches August 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - August 26, 2015 - The Morgan Leary Vaughan Fund, Inc.
ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs
ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015 - ALPCO
Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit
Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations
Anaemia Screening Digital Health Tech Takes Top Prize in 2015 MedTech’s Got Talent
Eyenaemia won an additional $40,000 cash prize to accelerate their anaemia screening platform toward commercialisation after beating out four other top teams at the closed-door Investor Boardroom Pitch, the final stage of the 2015 round of MedTech’s Got Talent. - August 21, 2015 - STC
Research Conducted by Dr. Antonio Medina at MIT Demonstrates That Glasses Worsen Eyesight
The latest research published in print this month demonstrates that wearing glasses worsens nearsightedness (myopia). Graefes Arch Clin Exp Ophthalmol (2015) 253:1273-1277. Medina’s feedback model for emmetropization predicts that correction of myopes aggravates their condition and myopia... - August 19, 2015 - Antonio Medina
St. Louis Motorcyclists Rev It Up at Ride for Kids
St. Louis motorcyclists gathered over the weekend to honor 11 local brain tumor survivors at the Pediatric Brain Tumor Foundation's Ride for Kids event. The family-friendly event, held at St. Charles Community College in Cottleville, raised $46,290 to support the foundation's lifesaving research... - August 19, 2015 - Pediatric Brain Tumor Foundation
Hometown Urgent Care to Open Third Clinic Off I-94
Hometown Urgent Care to open third clinic off I-94. Expansion makes Hometown largest urgent care provider for Kalamazoo and Portage residents. - August 17, 2015 - Hometown Urgent Care
Matrix Medical Announces Strategic Partner Plan with Key Hospitals
Matrix Medical announces new strategic partners for the Tractus product line. The product plans to solve the FDA direct part marking requirement pursuant to the FDA Final Rule pertaining to the UDI requirement. - August 17, 2015 - Matrix Medical Tracking Systems
NanoHybrids Launches Gold Nanoparticles Custom Designed to Improve Lateral Flow Quality and Reproducibility
Careful selection of indicator particles is absolutely critical to the performance of any lateral flow assay. NanoHybrids’ new line of monodisperse gold nanoparticles can enable the development of lateral flow assays that meet the highest specifications of the industry, particularly with respect to sensitivity and reproducibility. - August 16, 2015 - NanoHybrids
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
Matrix Medical Releases TRACTUS Video, World's First Sterile Scanner Showcased
Matrix Medical, a Wisconsin company, has unveiled the first ever sterile scanner, TRACTUS. A video has been released showcasing how the scanner can easily scan 2D data matrix codes in the sterile field. - August 09, 2015 - Matrix Medical Tracking Systems
Dr Nader N Youssef Appointed Chief Medical Officer of electroCore
Dr Nader N Youssef has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore. He was previously Executive Director GI Global Clinical Development... - August 09, 2015 - electroCore
TRACTUS Launched as Comprehensive Solution to FDA UDI Final Rule
Medical devices are an integral part of the health care system. Advances in devices and implants has led to a longer and improved quality of life for countless patients. However, not all interactions with medical devices have proven trouble-free. Recalls, Adverse events, and post-market... - August 07, 2015 - Matrix Medical Tracking Systems
Fertility Preservation Network Welcomes Huntington, West Virginia Area Facility
Program greatly extends access to fertility preservation services. - August 07, 2015 - ReproTech, LLC